Differential intervention of sodium polystyrene sulfonate versus calcium polystyrene sulfonate in patients with chronic kidney disease and hyperkalemia
Not Applicable
Recruiting
- Conditions
- Chronic kidney disease with hyperkalemia
- Registration Number
- JPRN-UMIN000012443
- Lead Sponsor
- Shonan Kamakura General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who corresponds to either of the following cannot participate in this clinical study 1)Patients on dialysis 2)Patients receiving oral hypoglycemic agents that might influence the insulin resistance (thiazolidine, biguanide, DPP-4 inhibitors, and drug combination comprising these component), insulin preparation, or GLP-1 receptor agonists 3)Patients who are allergic to targeted medication 4)Patients with intestinal obstruction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum potassium level
- Secondary Outcome Measures
Name Time Method 1)Serum bicarbonate level 2)Arteriosclerosis-related examination (coronary calcification score, and pulse wave velocity) 3)Insulin resistant (HOMA-R)